Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier
Press
May 11, 2020
BioWorld
TOC LINK
TOC LINK
Press
Published
May 11, 2020
More like this
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics Unveils Path to Exponentially Reducing the Cost of In Vivo Gene Delivery at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
May 9, 2024
Dyno Therapeutics Unveils Path to Exponentially Reducing the Cost of In Vivo Gene Delivery at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
May 9, 2024
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 14, 2025
343 Arsenal St
Watertown, MA 02472
© Dyno 2025
Privacy Policy
Terms + Conditions